• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二尖瓣活动性心内膜炎的修复与置换:9年经验

Repair versus replacement for active endocarditis of the mitral valve: 9 years of experience.

作者信息

Liu XinPei, Miao Qi, Liu XingRong, Zhang ChaoJi, Ma GuoTao, Liu JianZhou

机构信息

Department of Cardiac Surgery, Peking Union Medical College Hospital, Dongcheng, China.

Peking Union Medical College Hospital, Dongcheng, China.

出版信息

J Card Surg. 2022 Nov;37(11):3713-3719. doi: 10.1111/jocs.16904. Epub 2022 Sep 8.

DOI:10.1111/jocs.16904
PMID:36073065
Abstract

BACKGROUND AND AIM

To determine the factors contributing to successful mitral valve repair (MVP) and to discuss the effect of complex techniques on the durability of MVP for active infective endocarditis (IE) affecting the mitral valve.

METHODS

One hundred and eighty-seven patients were enrolled; 39.6% underwent mitral valve replacement (MVR) and 60.4% underwent MVP. We used logistic regression to identify influencing factors of the choice of surgical technique. The results were compared between groups and subgroups after propensity score matching (PSM).

RESULTS

Risk factors for MVR included poor valve quality (odds ratio [OR] 23.3, p = .001), a large defect after debridement (OR 16.4, p < .001), and heavy valve infection (OR 3.7, p = .027). After PSM, we did not find a significant difference in the frequency of major postoperative complications or the in-hospital or postdischarge death rate. The reintervention rate for MVP was significantly higher than that for MVR (p = .047). Subgroup analysis found a significant relationship between the use of a complex repair technique and the need for reoperation (p = .020).

CONCLUSIONS

The choice of valve repair or replacement for patients with active IE affecting the mitral valve was influenced by the intraoperative characteristics of the infected valve rather than the severity of systemic infection or overall health status. The choice of surgical treatment strategy had no effect on major postoperative complications, in-hospital mortality, or medium-term survival. However, the medium-term durability of MVP was poorer than that of MVR. The use of the patch technique for free margins or extensive leaflet defects was associated with a need for reintervention.

摘要

背景与目的

确定影响二尖瓣修复术(MVP)成功的因素,并探讨复杂技术对活动性感染性心内膜炎(IE)累及二尖瓣时MVP耐久性的影响。

方法

纳入187例患者;39.6%接受二尖瓣置换术(MVR),60.4%接受MVP。我们使用逻辑回归来确定手术技术选择的影响因素。倾向评分匹配(PSM)后对组间和亚组结果进行比较。

结果

MVR的危险因素包括瓣膜质量差(比值比[OR]23.3,p = 0.001)、清创后缺损大(OR 16.4,p < 0.001)和瓣膜感染严重(OR 3.7,p = 0.027)。PSM后,我们未发现术后主要并发症发生率、住院期间或出院后死亡率有显著差异。MVP的再次干预率显著高于MVR(p = 0.047)。亚组分析发现,使用复杂修复技术与再次手术需求之间存在显著关联(p = 0.020)。

结论

对于累及二尖瓣的活动性IE患者,瓣膜修复或置换的选择受感染瓣膜的术中特征影响,而非全身感染的严重程度或整体健康状况。手术治疗策略的选择对术后主要并发症、住院死亡率或中期生存率无影响。然而,MVP的中期耐久性比MVR差。使用补片技术修复游离缘或广泛的瓣叶缺损与再次干预需求相关。

相似文献

1
Repair versus replacement for active endocarditis of the mitral valve: 9 years of experience.二尖瓣活动性心内膜炎的修复与置换:9年经验
J Card Surg. 2022 Nov;37(11):3713-3719. doi: 10.1111/jocs.16904. Epub 2022 Sep 8.
2
Mitral valve surgery in acute infective endocarditis: long-term outcomes of mitral valve repair versus replacement.急性感染性心内膜炎的二尖瓣手术:二尖瓣修复与置换的长期结果。
J Cardiovasc Med (Hagerstown). 2024 Jan 1;25(1):30-37. doi: 10.2459/JCM.0000000000001544. Epub 2023 Aug 2.
3
Valve replacement or repair in native mitral valve infective endocarditis-Which is better? A meta-analysis and systematic review.在感染性心内膜炎患者中行二尖瓣置换术或修复术,哪种方法更好?一项荟萃分析和系统评价。
J Card Surg. 2022 Apr;37(4):1004-1015. doi: 10.1111/jocs.16227. Epub 2022 Jan 14.
4
Surgical results of active infective native mitral valve endocarditis: repair versus replacement.主动感染性原生二尖瓣心内膜炎的手术结果:修复与置换。
Eur J Cardiothorac Surg. 2011 Oct;40(4):834-9. doi: 10.1016/j.ejcts.2011.01.016. Epub 2011 Apr 3.
5
Should more patients be offered repair for mitral valve endocarditis? a single-centre 15-year experience.是否应向更多的二尖瓣心内膜炎患者提供修复治疗?单中心 15 年经验。
J Cardiothorac Surg. 2022 Sep 30;17(1):243. doi: 10.1186/s13019-022-01997-2.
6
To repair or to replace in mitral valve infective endocarditis? an updated meta-analysis.在二尖瓣感染性心内膜炎中,是修复还是置换?一项更新的荟萃分析。
J Cardiothorac Surg. 2024 Apr 18;19(1):247. doi: 10.1186/s13019-024-02767-y.
7
Surgical treatment of active native mitral infective endocarditis: A meta-analysis of current evidence.外科治疗活动性原发性二尖瓣感染性心内膜炎:当前证据的荟萃分析。
J Chin Med Assoc. 2018 Feb;81(2):147-154. doi: 10.1016/j.jcma.2017.08.017. Epub 2017 Oct 16.
8
Long-term outcomes following repair or replacement in degenerative mitral valve disease.退行性二尖瓣疾病修复或置换后的长期预后。
Thorac Cardiovasc Surg. 2010 Oct;58(7):415-21. doi: 10.1055/s-0029-1240925. Epub 2010 Oct 4.
9
Comparative efficacy and safety of mitral valve repair versus mitral valve replacement in Rheumatic heart disease: A high-value care systematic review and meta-analysis.风湿性心脏病中二尖瓣修复术与二尖瓣置换术的疗效和安全性比较:一项高价值医疗系统评价与荟萃分析
Curr Probl Cardiol. 2024 Jun;49(6):102530. doi: 10.1016/j.cpcardiol.2024.102530. Epub 2024 Mar 20.
10
Patient and Surgeon Predictors of Mitral and Tricuspid Valve Repair for Infective Endocarditis.感染性心内膜炎患者与外科医生对二尖瓣和三尖瓣修复术的预测因素。
Semin Thorac Cardiovasc Surg. 2022 Spring;34(1):67-77. doi: 10.1053/j.semtcvs.2021.03.017. Epub 2021 Apr 15.